期刊文献+

基因治疗病毒载体的研究进展 被引量:11

Study Advancement of Viral Vector for Gene Therapy
下载PDF
导出
摘要 基因转移载体是基因治疗的重要组成部分,包括病毒载体和非病毒载体。目前应用的病毒载体主要有逆转录病毒载体、腺病毒载体、腺病毒相关病毒、慢病毒载体、单纯疱疹病毒载体等。不同的病毒载体各有利弊。随着对病毒载体的不断改造完善,提高其基因转移效率和安全性,病毒载体将在基因治疗中继续发挥重要作用。 Gene transfer vector is the important ingredient in gene therapy, which includes virus vector and nan-vires vector. At present, the mainly applied virus vectors are retroviral vector, adenovirus vector adenovirus-associated virus slow virus vector, herpes simplex virus vector and so on. Different viruses have their own advantages and disadvantages. With the increasing reform and consummation of virus vector, it can play its important role continuously in gene therapy by promoting its efficacy and safty in gene transfer.
出处 《医学综述》 2007年第7期490-492,共3页 Medical Recapitulate
关键词 基因治疗 病毒载体 逆转录病毒载体 Gene therapy Viral vector Retrovirus vector
  • 相关文献

参考文献17

  • 1Lundstrom K.Latest development in viral vectors for gene therapy[J].Trends Biotechnol,2003,21 (3):117-122.
  • 2王红卫,薛京伦.VSV-G假型反转录病毒载体在基因治疗中的应用[J].国外医学(遗传学分册),2001,24(1):11-13. 被引量:4
  • 3Majhen D,Ambriovic-Ristov A.Adenoviral vectors-How to use them in cancer gene therapy?[J].Virus Res,2006,119(2):121-133.
  • 4Vorburger SA,Hunt KK.Adenoviral gene therapy[J].Oncologist,2002,7(1):46-59.
  • 5Stoff-Khalili MA,Stoff A,Rivera AA,et al.Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system[J].Cancer Biol Ther,2005,4(11):1203-1210.
  • 6Shinozaki K,Suominen E,Carrick F,et al.Efficient infection of tumor endothelial cells by a capsid-modified adenovirus[J].Gene Ther,2006,13(1):52-59.
  • 7TsukudaK,Wiewrodt R,Molnar-Kimber K,et al.An E2F-responsive replication-selective adenovirus targeted to the defective cell cycle in cancer cells:potent antitumoral efficacy but no toxicity to normal cell[J].Cancer Res,2002,62(12):3438-3447.
  • 8Huang TG,Savontaus MJ,Shinozaki K,et al.Telomerase-dependent oncolytic adenovirus for cancer treatment[J].Gene Ther,2003,10(15):1241-1247.
  • 9Carter BJ.Adeno-associated virus vectors in clinical trials[J].Hum Gene Ther,2005,16(5):541-550.
  • 10孙小娟,谭孟群.腺相关病毒载体应用的研究进展[J].国外医学(生理病理科学与临床分册),2003,23(6):588-590. 被引量:5

二级参考文献42

  • 1Vanden-Driessche T, Vanslembrouck V, Goovaerts I, et al.Long-term expression of human coagulation factor Ⅷ and correction of hemophilia A after in vivo retroviral gene transfer in factor Ⅷ-deficient mice. Proc Natl Acad Sci U S A, 1999, 96:10379-10384.
  • 2Connelly S, Smith TA, Dhir G, et al. In vivo delivery and expression of physiological levels of functional human factor Ⅷ in mice. Hum GeneTher, 1995,6:185-193.
  • 3Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science, 1996,272:263-267.
  • 4Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.Nat Genet, 1997,17:314-317.
  • 5Xu K, Ma H, McCown TJ, et al. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther, 2001,3:97-104.
  • 6Buchschacher GL Jr, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. Blood, 2000, 95:2499-2504.
  • 7Sirven A, Pflumio F, Zennou V, et al. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood, 2000,96: 4103-4110.
  • 8Park F, Kay MA. Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol Ther, 2001, 4:164-173.
  • 9Srivastava A. Delivery system for gene therapy : adeno-associated virus 2 [J]. Stem Cell Biol Gene Ther,1998,257-285.
  • 10Joseph E, Rabinowitz, Samulski RJ. Building a better vector: the manipulation of AAV virions[J]. Virology,2000,278:301-308.

共引文献25

同被引文献109

引证文献11

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部